Disposición para participar en investigación en población adictaprevalencia y factores asociados

  1. Inés Morán-Sánchez 1
  2. Aurelio Luna 2
  3. María Dolores Pérez-Cárceles 2
  1. 1 Centro de Salud Mental Cartagena, Servicio Murciano de Salud
  2. 2 Universidad de Murcia
    info

    Universidad de Murcia

    Murcia, España

    ROR https://ror.org/03p3aeb86

Journal:
Adicciones: Revista de socidrogalcohol

ISSN: 0214-4840

Year of publication: 2019

Volume: 31

Issue: 2

Pages: 95-105

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Adicciones: Revista de socidrogalcohol

Abstract

Greater attention is focusing on the motivations of subjects recruited for research protocols, especially in vulnerable populations. Although addiction is a highly stigmatized condition, very little research has focused on the factors influencing the decision to participate of patients with an addiction. Our aim is to gather further evidence in relation to the motivations of people with Substance Use Disorders (SUD), comparing their reasoning and willingness to participate in a hypothetical research study of 53 subjects with DSM-5 diagnoses of SUD and 50 controls. Responses on the MacArthur Competence Assessment Tool for Clinical Research were documented and correlated with several variables. There were no significant differences in willingness to participate in research and reasons for doing so between SUD and controls. Among SUD subjects, 59% mentioned altruism, 53.8% expected therapeutic benefits, and 43.6% desired to help others; none mentioned money. Of those patients with SUD who refused to participate in research, 69.2% cited aversion and 46.2% mentioned risk. Willingness to participate was correlated with higher computer literacy and better cognitive performance. In the multivariate analysis, aversion was a significant predictor of willingness to participate in research. When research is not related to their diagnosis, the motivations of SUD and controls are similar and flowed logically from the study. However, elements associated with therapeutic misconceptions were also evident. Therefore, negative views about the motivations of SUD subjects’ participation in research are unfounded. Consequently, to improve study recruitment, assessments may be targeted to specific vulnerabilities rather than to diagnoses.

Bibliographic References

  • Aguayo, M. (2010). Cómo hacer una Regresión Logística con SPSS “ paso a paso” (I). Fundación Andaluza Beturia para la Investigación en Salud, 1-16.
  • American Psychiatric Association (2014). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). Washington DC: American Psychiatric Publishing.
  • Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto P.,… AdICoNA Study Group. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndrome, 31, 123-127.
  • Appelbaum, P. S. y Grisso, T. (2001). MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Professional. Sarasota, FL: Professional Resource Press.
  • Baón, B. S. (2013). Adaptación y Validación Española de la Entrevista Macarthur Competency Assessment Tool for Clinical Research (MacCAT-CR) y de un Cuestionario Breve para Evaluar la Capacidad de las Personas para Consentir Participar en Investigación. Tesis Doctoral en Formato Electrónico. Madrid: Repositorio Institucional E-Prints Universidad Complutense.
  • Barrat, M. J., Norman, J. S. y Fry C. L. (2007). Positive and negative aspects of participation in illicit drug research: Implications for recruitment and ethical conduct. International Journal of Drug Policy, 18, 235-238. doi:10.1016/j. drugpo.2006.07.001.
  • Beauchamp, T. L. y Childress, J. F. (2009). Principles of Biomedical Ethics. (6th ed.). New York: Oxford University Press.
  • Brintnall-Karabelas, J., Sung, S, Cadman, M. E., Squires, C., Whorton, K. y Pao, M. (2011). Improving Recruitment in Clinical Trials: Why Eligible Participants Decline. Journal of Empirical Research on Human Research Ethics, 6, 69-74. doi:10.1525/jer.2011.6.1.69.
  • Candilis, P. J., Geppert, C. M., Fletcher, K. E., Lidz, C. W. y Appelbau, P. S. (2006). Willingness of subjects with thought disorder to participate in research. Schizophrenia Bulletin, 32,159-165. doi:10.1093/schbul/sbj016.
  • Carter, A. y Hall, W. (2012). Ethics of addiction research. En Edwards, G. (Ed.), Addiction Neuroethics. The Promises and Perils of Neuroscience Research on Addiction (pp. 146160). New York: Cambridge University Press.
  • Dunn, L. B., Kim, D. S., Fellows, I. E. y Palmer, B. W. (2009). Worth the risk? Relationships of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophrenia Bulletin, 35, 730737. doi:10.1093/schbul/sbn003.
  • Endicott, J., Spitzer, R. L., Fleis, J. L. y Cohen, J. (1976). The Global Assessment Scale: A procedure for measuring overall Severity of Psychiatric disturbance. Archives of General Psychiatry, 33, 766-771.
  • Fry, C. L. y Dwyer, R. (2001). For love or money? An exploratory study of why injecting drug users participate in research. Addiction, 96, 1319-1325. doi:10.1080/09652140120070373.
  • Fry, C. L., Hall, W., Ritter, A. y Jenkinson, R. (2006a). The Ethics of Paying Drug Users Who Participate in Research: a Review and Practical Recommendations. Research Subject Payment Ethics, 1, 21-36. doi:10.1525/ jer.2006.1.4.21.
  • Fry, C. L., Madden, A., Brogan, D. y Loff, B. (2006b). Australian resources for ethical participatory processes in public health research. Journal of Medical Ethics, 32, 186. doi:10.1136/jme.2005.013243.
  • Geppert, C. M., Candilis, P. J., Baker, S., Lidz, C. W. y Appelbaum, P. S. (2014). Motivations of Patients with Diabetes to Participate in Research. AJOB Empirical Bioethics, 5, 1421. doi:10.2105/AJPH.2014.301881.
  • Guy, W. (1976). Clinical Global Impression Scale. En Guy, W. (Ed.), ECDEU Assessment Manual for Psychopharmacology (pp. 217-223). Rockville: Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration.
  • Jansen, L. A. (2006). The Problem with Optimism in Clinical Trials. IRB: Ethics & Human Research, 28, 13-19.
  • Lawton, J., Snowdon, C., Morrow, S., Norman, J. E., Denison, F. C. y Hallowell, N. (2016). Recruiting and consenting into a peripartum trial in an emergency setting: a qualitative study of the experiences and views of women and healthcare professionals. Trials, 17, 1-14. doi:10.1186/s13063-016-1323-3.
  • Lebensburger, J. D., Sidonio, R.F., DeBaun, M. R., Saffor, M. M., Howard, T. H. y Scarinci, I. C.(2013). Exploring Barriers and Facilitators to Clinical Trial Enrollment in the Context of Sickle Cell Anemia and Hydroxyurea. Pediatric Blood & Cancer, 60, 1333-1337. doi:10.1002/ pbc.24486.
  • Lobo, A., Saz, P., Marcos, G., Día, J. L., de la Cámara, C., Ventura, T.,… Aznar, S. (1999). Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Medicina Clínica, 112, 767774.
  • MacNeil, S. D. y Fernández, C. V. (2006). Informing research participants of research results: Analysis of Canadian university based research ethics board policies. Journal of Medical Ethics, 32, 49-54. doi:10.1136/ jme.2004.010629.
  • Marrugat, J., Vila, J., Pavesi, M. y Sanz F. (1999). Estimación del tamaño de la muestra en la investigación clínica y epidemiológica. Medicina Clínica, 111, 267-276.
  • Misra, S., Socherman, R., Park, B. S., Hauser, P. y Ganzini, L. (2008). Influence of mood state on capacity to consent to research in patients with bipolar disorder. Bipolar Disorder, 10, 303-309. doi:10.1111/j.13995618.2007.00525.x.
  • Morán-Sánchez, I., Luna, A., Sánchez, M., Aguilera, B. y Pérez-Cárceles, M. D. (2016). Decision-making Capacity for Research Participation among Addicted People: a cross-sectional study. BMC Medical Ethics, 17, 1-10. doi:10.1186/s12910-015-0086-9.
  • Morera, B. (2000). Aspectos bioéticos de la asistencia al drogodependiente. Adicciones, 12, 515-526.
  • Mullin, S. (2002). Communicating risk: closing the gap between perception and reality. Journal of Urban Health, 79, 296-297. doi:10.193/jurban/79.3.296.
  • Nogué, S. y Miró, O. (2015). Núcleos y ámbitos de investigación sobre adicciones: necesidad de una visión más amplia. Adicciones, 27, 75-76.
  • Nuñez, E., Steyerberg, E. W. y Nuñez, J. (2011). Regression modeling strategies. Revista Española de Cardiología, 64, 501-507. doi:10.1016/j.recesp.2011.01.019.
  • Ortega, M. y Cayuela, A. (2002). Regresión logística no condicionada y tamaño de muestra: una revisión bibliográfica. Revista Española de Salud Pública, 76, 85-93.
  • Real Decreto 1090/2015, de 4 de diciembre por el que se regulan los ensayos clínicos con medicamentos, los Comités de Ética de la Investigación con medicamentos y el Registro Español de Estudios Clínicos. Boletín Oficial del Estado. Madrid, 24 de diciembre de 2015, núm.307, pp. 121923-121964.
  • Roberts, L. W., Warner, T. D., Anderson, C. T., Smithpeter, M. V. y Rogers, M. K. (2004). Schizophrenia research participants’ responses to protocol safeguards: recruitment, consent, and debriefing. Schizophrenia Research, 67, 283-291.
  • Roberts, L. W., Warner, T. D., Brody, J. L., Roberts, B., Lauriello, J. y Lyketsos, C. (2002). Patient and Psychiatrist Ratings of Hypothetical Schizophrenia Research Protocols: Assessment of Harm Potential and Factors Influencing Participation Decisions. American Journal of Psychiatry, 159, 573-584.
  • Seelig, B. J. y Dobelle, W. H. (2001). Altruism and the Volunteer: Psychological Benefits from Participating as a Research Subject. ASAIO Journal, 47, 3-5.
  • Stanley, B. y Stanley, M. (1982). Testing competency in psychiatric patients. IRB, 4, 1-6.
  • Stroup, T. S., Appelbaum, P. S., Swartz, M. S., Patel, M., Davis, S., Jeste, D. V.,… Lieberman, J.(2005). Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophrenia Research, 80, 1-8. doi:10.1016/j.schres.2005.08.007.
  • Tromp, K., Zwaan, C. M. y van de Vathorst, S. (2016). Motivations of children and their parents to participate in drug research: a systematic review. European Journal of Pediatrics, 175, 599-612. doi:10.1007/s00431-016-2715-9.
Data source: Dialnet